Similarly, miR-126 has been shown to regulate endothelial cell migration and angiogenesis by targeting the PI3K-Akt pathway (associated with approximately 70% of ovarian cancers), which is downstream of integrin signaling [71,72]. The gene discussed is AKT1; the disease is ovarian cancer.